Published January 1, 2014 | Version v1
Journal article Open

Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy

  • 1. Univ New S Wales, Sch Chem, Ctr Adv Macromol Design, Sydney, NSW 2052, Australia

Description

Fructose transporter GLUT5 is overexpressed in breast cancer cell lines, but not in healthy tissue. Micelles based on fructose, which were found to be low fouling, showed a high uptake by breast cancer cells (MCF-7 and MDA-MB-231 cells), but only negligible uptake by macrophages.

Files

bib-28e095fb-7b8b-4f58-bcb4-fc5483446c99.txt

Files (227 Bytes)

Name Size Download all
md5:c166cd55291fd1d3b452b4e3cf1ae69a
227 Bytes Preview Download